Sonova H Ag

Sonova Holding AG manufactures and sells hearing care solutions for children and adults across Switzerland, the United States, the rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Hearing Instruments, Cochlear Implants, and Lifestyle-Aligned. The Hearing Instruments segment designs, develops, manufactures, distributes, and services hearing instruments and related products, including wireless headsets, speech-enhanced hearables, and audiophile headphones under brands such as Phonak, Unitron, Hansaton, and Sennheiser, and provides audiological care services under brands including AudioNova, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing. The Cochlear Implants segment offers similar activities under the Advanced Bionics brand, while the Lifestyle-Aligned segment designs connected solutions integrating AI and digital capabilities. The company sells directly to consumers through its own store network, wholesales to independent audiologists, third-party retail chains, and multinational and government customers, and provides hearing care services through a network of stores and clinics. Formerly known as Phonak Holding AG, it changed its name to Sonova Holding AG in August 2007, was founded in 1947, and is headquartered in Stäfa, Switzerland.

SOON.SW▲

Sonova Holding AG Reports 17.3% Rise in Normalized EBITDA to $794 Million

Sonova Holding AG reported a 17.3% increase in normalized EBITDA to $794 million for fiscal year 2025-26, with the margin improving 240 basis points in local currencies to 23.7%. Total segment sales rose 7.5% to $3.4 billion, driven by a 9.5% increase in wholesale revenues to $1.9 billion and a 5.1% rise in retail revenue to $1.5 billion. Cochlear implant sales reached $252 million, down 11% overall, or 3.8% lower excluding China, amid competitive pressure and the introduction of VDP in China. Exchange rate developments negatively impacted normalized EBITDA by CHF130 million, reducing the margin by 1.5 percentage points. The company proposed a 7% dividend increase to 4.70 per share and issued an outlook for fiscal 2026-27 of 5% to 8% consolidated sales growth and 7% to 10% core EBIT growth at constant exchange rates.

SOON.SW ▲

GuruFocus·93dRead more →